1. Home
  2. TBLD vs TECX Comparison

TBLD vs TECX Comparison

Compare TBLD & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thornburg Income Builder Opportunities Trust

TBLD

Thornburg Income Builder Opportunities Trust

N/A

Current Price

$20.58

Market Cap

713.5M

Sector

Finance

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$19.06

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TBLD
TECX
Founded
2021
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
713.5M
618.9M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
TBLD
TECX
Price
$20.58
$19.06
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $71.00
AVG Volume (30 Days)
53.2K
★ 169.5K
Earning Date
01-01-0001
11-13-2026
Dividend Yield
★ 6.12%
N/A
EPS Growth
N/A
★ 40.70
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.48
$15.60
52 Week High
$23.02
$39.53

Technical Indicators

Market Signals
Indicator
TBLD
TECX
Relative Strength Index (RSI) 53.27 27.37
Support Level $19.80 $16.77
Resistance Level $20.67 $22.44
Average True Range (ATR) 0.26 1.09
MACD 0.07 0.10
Stochastic Oscillator 90.40 9.99

Price Performance

Historical Comparison
TBLD
TECX

About TBLD Thornburg Income Builder Opportunities Trust

Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: